Living meta-analysis of 3 observational studies: paternal valproate vs lamotrigine or levetiracetam during spermatogenesis was not associated with offspring neurodevelopmental disorders (pooled HRs 1.03-1.06, e.g. 1.05, 95% CI 0.87-1.27).
Meta-analysisn = 3 studies
Christensen et al. Risk of neurodevelopmental disorders associated with paternal use of valproate during spermatogenesis: a living meta-analysis-version 1